Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines for cervical cancer.

C M Lowndes

    Epidemiology and Infection
    |January 18, 2006
    PubMed
    Summary

    Preventing invasive cervical cancer (ICC) is advancing with HPV vaccines. These vaccines target high-risk human papillomavirus (HPV) types, offering hope for significant ICC reduction globally.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnostic accuracy of a prototype rapid chlamydia and gonorrhoea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
    Same author

    A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy.

    EBioMedicine·2018
    Same author

    Who mixes with whom among men who have sex with men? Implications for modelling the HIV epidemic in southern India.

    Journal of theoretical biology·2014
    Same author

    Diagnostics, surveillance and management of sexually transmitted infections in Europe have to be improved: lessons from the European Conference of National Strategies for Chlamydia Trachomatis and Human Papillomavirus (NSCP conference) in Latvia, 2011.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2012
    Same author

    Do HIV-infected individuals test for sexually transmitted infections at another sexual health clinic?

    Sexually transmitted infections·2011
    Same author

    Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance.

    HIV medicine·2011

    Area of Science:

    • Gynecologic Oncology
    • Vaccinology
    • Public Health

    Background:

    • Invasive cervical cancer (ICC) remains a significant global health challenge, particularly in developing nations.
    • Cytological screening programs (Pap smears) have reduced ICC mortality in some regions, but are difficult to implement universally.
    • High-risk human papillomavirus (HPV) infection is the primary cause of ICC.

    Discussion:

    • Primary prevention through HPV vaccination offers a promising strategy to reduce ICC incidence and mortality.
    • Current HPV vaccines demonstrate high efficacy against type-specific HPV infections and pre-cancerous lesions.
    • Vaccination is especially critical for developing countries bearing the highest ICC burden.

    Key Insights:

    • HPV types 16 and 18 are responsible for approximately 70% of cervical cancer cases worldwide.
    • Monovalent and bivalent HPV vaccines show significant promise in preventing HPV-related pre-cancerous lesions.
    • Large-scale Phase III trials are evaluating the efficacy and safety of various HPV vaccine candidates.

    Outlook:

    • An effective HPV vaccine targeting HPV 16 and 18 could be available within two years.
    • Widespread HPV vaccination has the potential to dramatically decrease the global burden of invasive cervical cancer.
    • Continued research and implementation strategies are crucial for maximizing the impact of HPV prevention.

    Related Experiment Videos